Metoprolol in Dilated Cardiomyopathy

Metoprolol in Dilated Cardiomyopathy

A clinical trial that evaluated the cardiovascular effect of metoprolol, a beta blocker, on patients with idiopathic dilated cardiomyopathy.

Conclusion
Metoprolol was well-tolerated, reduced clinical deterioration, and improved symptoms and cardiac function, without reducing mortality.
References in periodicals archive ?
Of those identified, 2 trials each evaluated bisoprolol (the Cardiac Insufficiency Bisoprolol Study [CIBIS][11] and the Cardiac Insufficiency Bisoprolol Study II [CIBIS-II][12]), carvedilol (the Australia/New Zealand Heart Failure Research Collaborative Trial [ANZ][9] and the US Carvedilol Heart Failure Program [US Carvedilol][13]), and metoprolol (the Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure [MERIT-HF][3] and the Metoprolol in Dilated Cardiomyopathy [MDC][14] trial).